Pricing Log in Create free account

uniQure N.V. (QURE) vs Tyra Biosciences, Inc. (TYRA)

uniQure N.V. and Tyra Biosciences, Inc. are both Biotechnology companies. uniQure N.V. and Tyra Biosciences, Inc. are of similar size ($1.5B and $1.4B). Tyra Biosciences, Inc. has the higher net margin (0.00% vs −1,154.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Tyra Biosciences, Inc. leads on 10 and uniQure N.V. on 3.

Valuation

Metric QURE TYRA Biotechnology median
P/E n/m n/m 10.60
P/S 74.94 n/m 9.40
P/B 5.13 3.94 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 44.70 n/m 9.02
Earnings yield (16.22%) (11.38%) (32.88%)
Free cash flow yield (12.91%) (7.90%) (23.13%)

Profitability

Metric QURE TYRA Biotechnology median
Gross margin 93.85% 0.00% 68.51%
Operating margin (1,001.74%) 0.00% 0.00%
Net margin (1,154.84%) 0.00% 0.00%
Free cash flow margin (956.80%) 0.00% 0.00%
Return on equity (88.99%) (45.31%) (51.96%)
Return on assets (25.47%) (42.15%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric QURE TYRA Biotechnology median
Revenue growth (TTM) 28.04% — 6.76%
EPS growth (last fiscal year) 29.67% (33.11%) 29.88%
Revenue growth, 5-year CAGR (15.57%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric QURE TYRA Biotechnology median
Debt to equity 0.17 0.00 0.00
Current ratio 11.52 14.91 4.97
Net debt to EBITDA 3.36 1.94 1.01

Dividend

Metric QURE TYRA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric QURE TYRA Biotechnology median
Market cap 1.46b 1.44b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack